Trial Profile
Double Blind Placebo Study of Vildagliptin in Prehypertensives Type II Diabetics.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms PREDIAB
- 06 Nov 2009 New trial record